Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 673

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 673
---
 type:

                                                         Year Ended December 31, 2024                             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                            Oncology/      Other                  
                                                                           Immunology      Ventures        Total  
                                                                       (in US$ ’ 000)                             
  Invoiced Goods — Marketed Products                                          128,008      —             128,008  
  — Distribution                                                                    —      266,836       266,836  
  Services — Commercialization of Marketed Products                            52,485      —              52,485  
  — Research and development                                                      471      —                 471  
  License & Collaborations — Services                                          57,968      —              57,968  
  — Royalties                                                                  71,041      —              71,041  
  — Licensing                                                                  43,000      —              43,000  
  — Manufacturing supply                                                       10,392      —              10,392  
                                                                              363,365      266,836       630,201  
  Third parties                                                               362,894      262,982       625,876  
  Related parties (Note 23(i))                                                    471      3,854           4,325  
                                                                              363,365      266,836       630,201  

F-35

Table of Contents

Year Ended December 31, 2023
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────
Oncology/ Other
Immunology Ventures Total
(in US$ ’ 000)
Invoiced Goods - Marketed Products 83,087 - 83,087
 - Distribution - 309,383 309,383
Services - Commercialization of Marketed Products 48,608 - 48,608
 - Research and development 481 - 481
License & Collaborations - Services 80,397 - 80,397
 - Royalties 32,470 - 32,470
 - Licensing 278,855 - 278,855
 - Manufacturing supply 4,718 - 4,718
528,616 309,383 837,999
Third parties 528,135 301,119 829,254
Related parties (Note 23(i)) 481 8,264 8,745
528,616 309,383 837,999
Year Ended December 31, 2022
────────────────────────────────────────